Obliterative bronchiolitis: prevention.
Kallio
E A
EA
Transplantation Laboratory, Cardiopulmonary Research Unit, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland.
Koskinen
P K
PK
Tikkanen
J M
JM
Lemström
K B
KB
D000818:Animals; D001989:Bronchiolitis Obliterans / Q000276:immunology / Q000473:pathology / Q000517:prevention & control*; D002455:Cell Division; D003167:Complement Activation; D003586:Cytomegalovirus Infections / Q000150:complications; D006131:Growth Inhibitors / Q000494:pharmacology; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016040:Lung Transplantation / Q000009:adverse effects*; D008213:Lymphocyte Activation; D023421:Models, Animal; D009569:Nitric Oxide / Q000627:therapeutic use; D051381:Rats; D013601:T-Lymphocytes / Q000276:immunology; D014132:Trachea / Q000637:transplantation*; D014184:Transplantation, Homologous
D006131:Growth Inhibitors; D007166:Immunosuppressive Agents; D009569:Nitric Oxide